Beta cell cytoprotection using lentiviral vector-based iNOS-specific shRNA delivery

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

Abstract

Cytokine-induced beta cell pathophysiology is characterised by the induction of iNOS expression. Inhibition of iNOS expression protects beta cells from cytokine-mediated destruction. The development of vector-based shRNA strategies capable of stably suppressing iNOS expression may provide a novel platform to protect beta cells from cytokine toxicity. In this report the utility of lentiviral shRNA vectors to silence iNOS expression was evaluated with respect to insulinoma cell viability, the induction of iNOS expression and the accumulation of nitrite in a cytokine-induced beta cell toxicity model. Here, we report for the first time on the use of lentiviral vector-based shRNA delivery to efficiently suppress the IL-1 beta-mediated induction of iNOS expression, the accumulation of nitrite and provide significant protection against the cytotoxic effects of IL-1 beta exposure. Moreover, non-specific knockdown of endogenous beta cell nNOS did not occur. (c) 2007 Elsevier Inc All rights reserved.
Original languageEnglish (Ireland)
Number of pages6
JournalBiochem Biophys Res Commun
Volume357
Issue number1
DOIs
Publication statusPublished - 1 May 2007

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • McCabe C, O'Brien T

Fingerprint

Dive into the research topics of 'Beta cell cytoprotection using lentiviral vector-based iNOS-specific shRNA delivery'. Together they form a unique fingerprint.

Cite this